A randomised controlled trial of physical activity and cognitive training in older adults: the PhABHeaD study Authors: Nicolas Cherbuin, Joseph M Northey, Erin I Walsh, Richard A Burns, Hollie Speer, Nicholas Lawlis, Tergel Namsrai, Amanda Scott, Vicki McCarthy, Jo Lane, Jeroen J A van Boxtel, Amit Lampit, Anne Brüstle, Ben Rattray Published: 2026 ABSTRACT AbstractBackgroundRobust empirical evidence supports the effectiveness of physical and cognitive training in preventing and delaying cognitive decline. Emerging research suggests distinct neurobiological mechanisms underpin the effects of these different training modalities. An unresolved question is whether the mechanisms through which these training modalities impart their effect interact synergistically to improve cognitive outcomes, rather than exerting additive effects, differ. In addition, past research has been inconsistent in adequately controlling for or documenting the dosage of physical and/or cognitive training. Consequently, the aim of this study is to assess the relative effectiveness of physical and cognitive training conducted in isolation or concurrently, whilst rigorously controlling and documenting the treatment parameters.MethodsThis study is a three-arm randomised controlled trial conducted over a 3-month period, comparing cognitive training, physical activity, and a combination of both interventions. Older cognitively healthy participants (n = 126) aged 60–75 years will be recruited from the community. The physical only training will require participants to cycle on a cycle ergometer at above 60% of their age-predicted heart rate maximum for 50 min with a 3-min warm-up and cool-down period. The cognitive only training will require participants to complete up to five different cognitive tasks selected from a set of eight on the BrainHQ platform during each 50-min training session. The concurrent cognitive and physical training will require participants to undertake both treatments at the same time. Primary outcomes, assessed pre- and post- intervention, will include speed of processing and episodic memory assessed with the NIH Toolbox, as well as general driving skills assessed on a driving simulator.DiscussionFindings will inform the design of interventions and population health advice aimed at mitigating cognitive decline. If a substantial synergetic effect is detected, it may lead to the use of more widespread concurrent physical and cognitive training and the potential development of methods to make concurrent training practical. Findings will also provide important clarification as to the relative benefit of the two modes of training.Trial registrationProspective registration with Australia and New Zealand Clinical Trial Registry (ACTRN12624001088538) on 10th September 2024 and World Health Organisation International Clinical Trials Registry (U1111-1280-3851).Supplementary InformationThe online version contains supplementary material available at 10.1186/s13063-026-09681-9.Keywords: Physical activity, Cognition, Concurrent training, Randomised controlled trial, Driving Administrative information Note: the numbers in curly brackets in this protocol refer to SPIRIT checklist item numbers. The order of the items has been modified to group similar items (see http://www.equator-network.org/reporting-guidelines/spirit-2013-statement-defining-standard-protocol-items-for-clinical-trials/). Title {1a}A randomised controlled trial of physical activity and cognitive training in older adults: the PhABHeaD study.Trial registration {2a and 2b}.ACTRN12624001088538 Australia and New Zealand Clinical Trial Registry (www.anzctr.org.au)ANZCTR collects all items from the World Health Organization WHO Trial Registration Data Set, and the Physical Activity for Better Health and Drive (PhABHeaD) study protocol is recorded in the WHO International Clinical Trials Registry (U1111-1280-3851).Protocol version {3}10th September 2024, version 1Funding {4}The study is a cross-institutional collaboration between the Australian National University (ANU) and the University of Canberra (UC) which provide some salary and in-kind (research space and equipment) support. The study is in part funded by the ANU NRMA Driving Research Fund and Dementia Research and the Prevention Research Fund, which provide financial support for salaries, equipment, and other research costs.Author details {5a}Nicolas Cherbuin1Joseph M. Northey2Erin I. Walsh1Richard Burns1Hollie Speer3Nicholas Lawlis2,3Tergel Namsrai1Amanda Scott3Vicki McCarthy3Jo Lane1Jeroen J.A van Boxtel3,6Amit Lampit4Anne Brüstle5Ben Rattray21 National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia2 Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, Australia3 UC Research Institute for Sport and Exercise, University of Canberra, Australia4 Department of Psychiatry, University of Melbourne, Melbourne, Australia5 John Curtin School of Medical Research, Australian National University, Canberra, Australia6 Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, AustraliaName and contact information for the trial sponsor {5b}Australian National UniversityActon, ACT 2601AustraliaRole of sponsor {5c}The trial sponsor has played no role in the study design and implementation, data analysis and interpretation, or in the preparation and communication of the results. ACTRN12624001088538 Australia and New Zealand Clinical Trial Registry (www.anzctr.org.au) ANZCTR collects all items from the World Health Organization WHO Trial Registration Data Set, and the Physical Activity for Better Health and Drive (PhABHeaD) study protocol is recorded in the WHO International Clinical Trials Registry (U1111-1280-3851). Nicolas Cherbuin1 Joseph M. Northey2 Erin I. Walsh1 Richard Burns1 Hollie Speer3 Nicholas Lawlis2,3 Tergel Namsrai1 Amanda Scott3 Vicki McCarthy3 Jo Lane1 Jeroen J.A van Boxtel3,6 Amit Lampit4 Anne Brüstle5 Ben Rattray2 1 National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia 2 Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, Australia 3 UC Research Institute for Sport and Exercise, University of Canberra, Australia 4 Department of Psychiatry, University of Melbourne, Melbourne, Australia 5 John Curtin School of Medical Research, Australian National University, Canberra, Australia 6 Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia Australian National University Acton, ACT 2601 Australia Introduction Background and rationale {6a} Older age is associated with a progressive decline in cognitive abilities, with increasing risk of dementia. It is also associated with a reduction in quality of life and loss of independence linked to the development of chronic disease. It is estimated that 16% of the population will be aged 65 years and over by 2050 [1, 2], an age at which dementia rates begin doubling approximately every 6 years [3]. Age-associated cognitive decline is therefore a major and increasing concern. At least fourteen modifiable risk factors for dementia have been robustly identified, which collectively account for approximately 40% of all dementia cases [4]. Two particularly influential factors are cognitive engagement and physical activity. These factors exert their effect across the lifecourse and are amenable to modification through behaviour change and population-level literacy regarding the risks of dementia. Moreover, even relatively late changes in cognitive engagement (typically defined as deliberate, active involvement in cognitively demanding tasks/activity/training) and physical activity, at midlife or beyond, have been found to be efficacious [5, 6]. This is important because it provides an opportunity to engage individuals later in life at a time when they often become more concerned about their health and may have more time and motivation to dedicate to protective behaviours if they have not already done so previously. The beneficial effects of cognitive engagement and physical activity have already been extensively and convincingly demonstrated through numerous and often large randomised controlled trials of either cognitive or physical activity training, whose outcomes have been synthesised in several systematic reviews and meta-analyses [5, 6]. However, there remains a lack of evidence on two related aspects, including the relative benefit of cognitive training compared to physical activity training, and the possible benefit of combining them. The neurobiological mechanisms underlying the beneficial effects of cognitive engagement and physical activity are not fully understood. However, the available evidence indicates that they differ in important ways including the neurotransmitters involved and the neuroplastic changes they produce, the brain regions and the cognitive functions they influence, and the other risk factors for neurodegeneration they may moderate [7–9]. Consequently, it is reasonable to assume that concurrently engaging in cognitive training and physical activity may lead to synergistic effects. The activity engagement theory [10] suggests that engagement in social, physical, and cognitive activities in later adulthood can prevent decline in cognitive performance [11]. There is substantial evidence that each element can play a role. Early-life education is thought to contribute greatly to developing an individual’s brain and cognitive reserve which may then be conserved in older adulthood through ongoing engagement in cognitively stimulating activities. Participating in cognitively stimulating activities at around 64–74 years has been associated with better cognitive performance several years later [12], even when attempting to account for reverse causation [13]. Moreover, our recent systematic reviews have demonstrated that when cognitive activity is manipulated as a specific training stimulus, typically for specific remediation purposes, such interventions are efficacious in maintaining or improving the targeted cognitive domains and to a lesser extent more global cognitive functions in older adults [14, 15] with small mean effect sizes. Increased cognitive activity clearly benefits cognitive outcomes, but more strongly when the training focuses on the same cognitive domains as those being assessed by outcome measures [16–19]. This specificity has been demonstrated by studies which investigate cellular mechanisms underpinning cognitive functions, functional brainactivation [18], but also through the redistribution of cerebral blood flow, supporting the metabolic demands of active regions. Active regions are also known to release brain-derived neurotrophic factor (BDNF) and other neural growth factors, supporting longer-term adaptations that build brain cognitive reserve over time [20]. Importantly, the influence of cognitive training interventions has been shown to benefit cognitive functions necessary to support activities of daily living and more complex demands associated with professional and other complex tasks [21]. Driving requires such complex cognitive skills and the research literature indicates that driving performance assessed in driving simulators, particularly in dual-tasking situations, may benefit driving skills and help maintain independence with age [22]. The role of physical activity in maintaining cognitive health in older individuals has also been demonstrated in recent meta-analyses [5, 23]. It is in part mediated by large elevations in cerebral blood flow [24], increased cerebral levels of BDNF and other neurotrophic factors [7], as well as by cellular and macroscopic brain changes [9]. In addition, physical activity training improves cardiovascular fitness which supports cognitive function by moderating the impact of at least four modifiable dementia risk factors including hypertension, diabetes, cardiovascular disease, and overweight [4]. It also has a positive impact on the sleep quality and mental health of older adults, which contribute to better cognitive function [25]. Together, these effects provide a strong evidence base demonstrating that physical activity training benefits cognitive health and mitigates cognitive decline. Importantly, meta-analyses indicate that interventions targeting both cognitive and physical training for cognitive function appear to be efficacious [26, 27]. Whilst the evidence in older adults for their superiority over physical-only training [26, 28] appears clear, combined training has been shown to provide additional cognitive benefits in some interventions [29] but not others [27]. There is currently insufficient evidence in humans that concurrent cognitive and physical training is superior for cognitive benefits compared to training those components alone or separately [30]. Current evidence is in its infancy with disparity among training interventions and limited systematic investigation of the mechanisms underpinning the beneficial effects of these interventions. Common criticisms of both cognitive and physical training research include the lack of a progressive overload training stimulus (i.e. the task progressively becoming harder), poor recording of training load characteristics, and lack of insight gained from the participant experience. This protocol describes a study to specifically address these limitations by investigating a physical activity intervention designed to produce the hypothesised benefits of concurrent training using a methodology that includes personalised and adaptive stimuli whilst monitoring their dosage and delivery, outcome measures aligned with training stimuli, as well as the investigation of participants’ subjective experience. To investigate the potential of increased adaptations due to concurrent physical and cognitive training, we aim to investigate whether concurrent training is superior to either physical or cognitive training alone. The primary outcomes of interest are participants’ driving skills, episodic memory, and processing speed. Given the recognised benefits of both cognitive and physical training in other domains, secondary outcomes include cardiovascular fitness, sleep quality, mental health, blood biomarkers, and the functioning in cognitive sub-domains not directly implicated in the specific cognitive training treatment. To do this, we will use a three-arm randomised controlled trial with 12-week training interventions in older adults. Comparisons will be made between physical only training, cognitive only training, and concurrent physical and cognitive training interventions. The enduring effects of the interventions will be assessed with a 12-week follow-up. The main features of the trial and its timeline are presented in Fig. 1 and in the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Fig. 2 and the SPIRIT checklist (supplementary material). Timeline of the trial’s main components, intervention arms, and assessments Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure outlining the timing of the different trial components Objectives {7} The over-arching aim of this study is to investigate the individual and combined/synergetic effects of physical activity and cognitive activity training, on cognitive function, driving skills, cardiovascular fitness, sleep quality, and mental health of older individuals. Additional aims include investigating changes in blood biomarkers related to the different treatments, and elucidating the mechanisms underlying the observed effects of the different interventions, as well as documenting the subjective experience of participants following them. Primary aim: Assess the relative effectiveness of concurrent physical and cognitive training administered in isolation or in combination in improving cognitive function and driving skills. Secondary aims: Investigate the underlying mechanisms of treatment effects through known mediators of cognitive and physical health to ascertain associations with improved physical and mental fitness on cognition and driving performance. Investigate the underlying mechanisms of treatment effects through known mediators of cognitive and physical health to ascertain associations with improved physical and mental fitness on cognition and driving performance. Study the effect of the different interventions on physical and mental health, and their relationship to other study outcomes. Study the effect of the different interventions on physical and mental health, and their relationship to other study outcomes. Explore the subjective experiences and acceptability to participants of a cognitive and physical training intervention to improve the development of future interventions. Explore the subjective experiences and acceptability to participants of a cognitive and physical training intervention to improve the development of future interventions. Trial design {8} Parallel three-arm randomised controlled trial (RCT) contrasting the effects of moderate physical only training, cognitive only training, or concurrent physical and cognitive training. Because the effectiveness of physical only and cognitive only training has already been extensively demonstrated against control conditions in RCTs and the evidence has been synthesised in systematic reviews and meta-analyses [5, 6], this trial does not include a non-active control but instead aims to test the superiority of concurrent physical and cognitive training relative to each condition tested individually. The participant allocation ratio to the three treatment groups is 1:1:1. There was no public involvement in the design of the trial, but it was informed by participants’ experience in previous interventions conducted by the research team. Methods: participants, interventions, and outcomes Study setting {9} This study takes place at a single site at the University of Canberra campus, in Canberra, Australia. Eligibility criteria {10} Inclusion criteria: Generally healthy sedentary to recreationally active older adults living in the community aged 60–75 years Generally healthy sedentary to recreationally active older adults living in the community aged 60–75 years Sufficient English proficiency to participate in all aspects of the study Sufficient English proficiency to participate in all aspects of the study Adequate corrected visual and auditory acuity necessary to undertake the assessment and intervention tasks Adequate corrected visual and auditory acuity necessary to undertake the assessment and intervention tasks Current and valid driver’s licence Current and valid driver’s licence Exclusion criteria: Major neurological conditions (dementia, Parkinson's, Multiple Sclerosis, stroke, etc.) Major neurological conditions (dementia, Parkinson's, Multiple Sclerosis, stroke, etc.) Major psychiatric conditions (major depressive disorder, schizophrenia, post-traumatic stress disorder, etc.) Major psychiatric conditions (major depressive disorder, schizophrenia, post-traumatic stress disorder, etc.) Physical impairments that preclude participation in the physical activity conditions Physical impairments that preclude participation in the physical activity conditions Major chronic conditions that may put participants at risk (e.g. unstable angina, chronic obstructive pulmonary disease, arrhythmias, etc.) Major chronic conditions that may put participants at risk (e.g. unstable angina, chronic obstructive pulmonary disease, arrhythmias, etc.) Significant visual or auditory impairment Significant visual or auditory impairment Who will take informed consent? {26a} Informed consent will be obtained through an online form (as approved by the Human Research Ethics Committee) after participants have been provided with a detailed information sheet and given an opportunity to ask questions either through the dedicated study email or during a phone call to be scheduled once they have communicated their interest in taking part in the study. It will be further confirmed when participants attend the baseline assessment in person. Additional consent provisions for collection and use of participant data and biological specimens {26b} As part of the consent process, participants will also be asked whether they consent to their data being retained beyond the end of the study for use in other studies and pooled analyses that may be approved through future ethics applications. Interventions Explanation for the choice of comparators {6b} Two active control groups, physical only training and cognitive only training, have been selected. This is because there is ample scientific evidence [5, 6, 15] demonstrating that these types of interventions are effective at delaying or slowing cognitive decline and therefore they are appropriate controls to test the superior efficacy of concurrent physical and cognitive training. Intervention description {11a} Physical only training. The physical only training arm requires participants to cycle on a stationary cycle ergometer (CXP Target Training Cycle, Matrix Fitness, Victoria, Australia) whilst watching low cognitively engaging YouTube videos (e.g. documentaries on nature and travel) from a preset video playlist on a Microsoft Surface tablet. Participants will be asked to cycle at 60–75% of their age-predicted heart rate maximum (APHRM = 208 − 0.7 × age) for 50 min with a 3-min warm-up and cool-down period either side (56 min total). The APHRM will be adapted if participants are deconditioned or if they report a very high rate of perceived exertion (RPE; > 15). The intervention will be delivered by an appropriately qualified exercise professional with experience working with the target population and will be delivered face-to-face at the University of Canberra clinical research laboratory. Over the 12-week intervention, participants will engage in two 50-min sessions each week, completing a total of 24 sessions. The use of the heartrate-based method for intensity will incite progressive overload as participants’ fitness will increase, requiring greater effort to increase heart rate. As the intervention is heart rate based for intensity, whilst the baseline requirement is the same, each participant’s experience will be personalised based on physical capabilities. Cognitive only training. The cognitive only training arm will require participants to sit in a quiet room and undertake cognitive training using the BrainHQ software on a Microsoft Surface tablet. The cognitive intervention will be delivered face-to-face at the University of Canberra clinical research laboratory by the same qualified professionals as those delivering the physical and concurrent interventions. Over the 12-week intervention, participants will engage in two 50-min sessions each week, completing a total of 24 sessions. The cognitive training from the BrainHQ software applies an adaptive overload principle, whereby the difficulty of training is decreased or increased depending on participant performance. Each level of a task adapts to ensure ~ 80% criterion accuracy (task-dependent) to be met across the level, typically 10–30 trials. Participant performance is compared against proprietary normative data to generate z-scores; lower-than-average performance requires repetition of the same level in future sessions whilst higher-than-average performance advances the participant to new, unique levels in future sessions. In each session, participants will complete up to four separate cognitive tasks from a set of six possible tasks that will rotate between sessions. They include target tracker, eye for detail, double decision, scene crasher, mind bender, and mental map. Brief descriptions of these tasks are presented in Table 1, and more details are available on the BrainHQ’s website (https://v4.brainhq.com.). Each unique level of a task introduces new stimulus parameters to both increase difficulty and promote generalisation. These parameters are task-dependent but rely on manipulations such as faster speed, harder stimulus discrimination, increased distractors, greater eccentricity, and reduced contrast. This increase in difficulty from one level to the next can therefore not be considered linear, although, broadly, difficulty was highest at the highest level. The training stimulus will be set to 38 levels per week, which equates to 19 levels and 45–50 min of work when completed at rest per session. Each level of a task will be actively adapted to achieve ~ 80% criterion accuracy (task-dependent) to be met across the level, typically 10–30 trials. The BrainHQ platform has been used previously to successfully enhance cognitive performance in older adults [31, 32]. Table 1BrainHQ training activitiesActivity name BrainHQ group Cognitive domain Associated outcome Double decisionAttentionVisual processing speedDriving/secondary cogTarget trackerAttentionSpatial attentionDriving/secondary cogEye for detailBrain speedVisual processing speed, visual working memoryPrimary cog/secondary cogScene crasherMemoryVisual working memoryPrimary cog/secondary cogMind benderIntelligenceCognitive flexibilityPrimary cog/secondary cogMental mapNavigationSpatial memorySecondary cog BrainHQ training activities Concurrent physical and cognitive training. The concurrent condition will require participants to simultaneously undertake the requirements outlined for the cognitive-only and physical-only training interventions. They will be cycling on a stationary cycle ergometer whilst engaging in specific cognitive tasks delivered through the BrainHQ software on a Microsoft Surface tablet mounted on the cycle ergometer using the same protocol as the cognitive only group. Participants will be advised to wait until the warm-up is completed before starting the cognitive training to ensure that the cognitive training takes place within the prescribed moderate intensity heart rate zone of the physical training condition. Criteria for discontinuing or modifying allocated interventions {11b} The allocation of interventions will not be modified except when sessions need to be rescheduled or cancelled due to unavoidable circumstances (e.g. illness). These modifications will be documented and controlled for in the analyses. Strategies to improve adherence to interventions {11c} Adherence to interventions will be promoted in several ways. Free nearby parking will be provided to ensure transportation issues do not become a disincentive. Study staff will foster a positive and supportive relationship with study participants. They will encourage feedback, acknowledge any concern raised, and where feasible implement remedial actions (e.g., softer/wider ergometer seats). Reminders of training sessions will be sent, and if a participant fails to attend a planned session, study staff will call them to determine why this occurred. Flexibility in re-scheduling and/or postponing sessions will be offered when participants experience difficulties, health concerns, or competing work and social engagements. Relevant concomitant care permitted or prohibited during the trial {11d} Participants are encouraged to maintain their normal routine and activity levels outside the trial sessions. No other recommendations or restrictions have been implemented. Provisions for post-trial care {30} As this trial does not involve the treatment of a clinical condition, there is no provision for post-trial care. However, participants are encouraged to maintain their activity level at the end of the trial. Outcomes {12} Primary outcomes Primary outcomes include cognitive function and general driving skills assessed at baseline and post intervention, at 13 weeks. The cognitive function outcome measures include the change from baseline to the end of the 12-week intervention in episodic memory and speed of processing, which are described below. These cognitive domains have been selected because existing research indicates that cognitive training benefits most episodic memory whilst physical activity training benefits most speed-of-processing [15]. Assessing both these domains will enable an explicit comparison of the relative contribution of each intervention component and its hypothesised synergetic effects. The driving skill outcome measures include average on-road speed, car headway, and response to changing road conditions. They have been selected because driving requires the combination of complex cognitive abilities, is often a concern in older adults, and is an ecologically relevant activity to probe transfer learning from the physical and cognitive training interventions. Secondary outcomes Secondary outcomes include additional cognitive (executive function, working memory, attention) and driving skills (standard deviation of lateral position and speed) measures, as well as wellbeing (World Health Organisation 5 Wellbeing Index; WHO-5), depression (Patient Health Questionnaire 9; PHQ-9), anxiety (Generalised Anxiety Disorder 7; GAD-7), sleep quality (Pittsburgh Sleep Quality Index; PSQI), sleep disturbances (Sleep Condition Indicator; SCI), objectively measured sleep characteristics (Actigraph), self-reported physical activity (International Physical Activity Questionnaire short form; IPAQ-SF), heart rate, blood pressure, grip strength, pulse wave velocity (PWV) and vascular stiffness, cardiorespiratory fitness, hand dexterity (Purdue Pegboard), dietary intake (Cancer Council Victoria diet questionnaire; DQES), intervention acceptability, and perceived workload. Driving skills, cardiorespiratory fitness, heart rate, blood pressure, intervention acceptability, objectively measured sleep characteristics, and perceived workload will be assessed at baseline and post intervention (13 weeks). All other measures will be assessed at baseline, post-intervention, and at a 3-month post-intervention follow-up (25 weeks). Participant timeline {13} Sample size {14} We will recruit 126 participants (42 per group) to meet our target of 114 participants (38 per group) allowing for an attrition rate of ~ 10% [23]. This target is achievable based on our experience and a 24-month participant-intake window. In making this calculation, we utilised the relative effect between simultaneous (concurrent) and physical training on cognitive outcomes (d = 0.24; f = 0.12) as reported in our recent meta-analysis [5] and calculated the sample size using G*power for three groups (80% power; α of 0.05). Recruitment {15} Recruitment will take place through channels specifically appropriate for the target population. This will include traditional news media, such as local radio (notably ABC radio Canberra’s Breakfast and Afternoons programmes) and classifieds in the Canberra Times, both of which have a wide reach among the older local community. We will also make use of age-targeted and location-targeted Facebook advertisements, as Facebook has wide representative reach in older populations [33]. If needed, flyers will be posted on community noticeboards located in local shops, libraries, and other community centres. Assignment of interventions: allocation Sequence generation {16a} The randomisation sequence was generated based on a random seed with the online resource ‘sealedenvelope.com’ using simple blocked randomisation with sex stratification. Concealment mechanism {16b} Sealed opaque envelopes. Implementation {16c} A research associate not involved in the assessment of outcomes generated the allocation sequence. The same research associate was also tasked with enrolling participants and assigning them to the intervention arms. Assignment of interventions: blinding Who will be blinded {17a} Specific research associates will be only involved in pre-, post-, and follow-up assessments, and will not otherwise contribute to overseeing the delivery of the intervention components or data curation and therefore will be blinded. Assessments will occur in different locations to those used to deliver the intervention. Those delivering the intervention components cannot be blinded given the nature of the intervention. Procedure for unblinding if needed {17b} There is no foreseeable circumstance under which unblinding is permissible beyond the limitations noted above. Data collection and management Plans for assessment and collection of outcomes {18a} All study data will be collected and managed using REDCap electronic data capture tools [34]. Data collection will proceed according to the following management plan and schedule: Week 1: A participant expresses interest in taking part in the study by phone or email and is provided with general information regarding what the study involves. A participant expresses interest in taking part in the study by phone or email and is provided with general information regarding what the study involves. A phone interview is scheduled to answer the participant’s questions, to conduct a brief verbal dementia screening assessment, and to obtain background health information necessary to assess inclusion/exclusion criteria. A phone interview is scheduled to answer the participant’s questions, to conduct a brief verbal dementia screening assessment, and to obtain background health information necessary to assess inclusion/exclusion criteria. If the participant would like to proceed, they are asked to review all the study explanatory documents, complete the online consent form, followed by demographics, physical activity behaviours, diet, acceptability, and mental health questionnaires (~ 1 h) If the participant would like to proceed, they are asked to review all the study explanatory documents, complete the online consent form, followed by demographics, physical activity behaviours, diet, acceptability, and mental health questionnaires (~ 1 h) Week 0: Assessment Day 1: University of Canberra (90–120 min) Greeting and introduction (5–15 min) Greeting and introduction (5–15 min) Pulse wave analysis and PWV (up to 25 min) Pulse wave analysis and PWV (up to 25 min) Cognitive battery (inclusive of grip strength and 9-hole peg test) (up to 60 min) Cognitive battery (inclusive of grip strength and 9-hole peg test) (up to 60 min) Blood draw (15–20 min) Blood draw (15–20 min) Fitted with an Actigraph monitor to wear for 2 weeks (week 0 and week 1) Fitted with an Actigraph monitor to wear for 2 weeks (week 0 and week 1) Assessment Day 2: University of Canberra (70 min) Driving-simulator assessment (45–50 min) Driving-simulator assessment (45–50 min) Cardiorespiratory fitness assessment (20 min) Cardiorespiratory fitness assessment (20 min) Weeks 1–12: Training intervention: activity as per randomisation conditions (50 min, 2 days/week at the University of Canberra) Training intervention: activity as per randomisation conditions (50 min, 2 days/week at the University of Canberra) Weeks 3, 6, 9: Physical only training: Data-rich cycle sessions Physical only training: Data-rich cycle sessions Cognitive only training: BrainHQ assessments Cognitive only training: BrainHQ assessments Concurrent: Data-rich cycle and BrainHQ assessment Concurrent: Data-rich cycle and BrainHQ assessment Week 13: Identical to week 0 assessment Identical to week 0 assessment Brief online survey including acceptability and dietary questionnaires (30 min) Brief online survey including acceptability and dietary questionnaires (30 min) Week 25: Cognitive battery (inclusive of grip strength and 9-hole peg test) (40 min) Cognitive battery (inclusive of grip strength and 9-hole peg test) (40 min) Fitted with an Actigraph monitor to wear for 1 week Fitted with an Actigraph monitor to wear for 1 week Brief online survey including acceptability and dietary questionnaire (30 min) Brief online survey including acceptability and dietary questionnaire (30 min) Measures Cognitive function Cognitive function will be assessed with the NIH Toolbox, which is a validated test battery designed to enable the consistent assessment of cognitive skills across populations, age groups, and clinical populations. It is implemented as an iPhone Operating System (iOS) app and designed for use with an iPad. Episodic memory will be assessed with the picture sequence memory test Form A. Participants will be shown a series of pictures presented in a specific order on the iPad screen along with verbal cues. After viewing the sequence, participants will be asked to recall the correct order of pictures on the screen. The total number of correctly recalled sequences will be recorded. Speed of processing will be assessed with the oral symbol digit test. Participants will be presented with a key that pairs unique symbols with single-digit numbers. Subsequently, they will be shown a series of symbols and asked to state aloud the corresponding digits as often as possible within 120 s. The total number of correct responses will be recorded as the primary measure for speed of processing performance. Executive function will be assessed with Trail Making Tasks A and B (paper) and the Dimensional Change Card Sort Test. In Trail Making Task A, participants will be instructed to connect the numbered circles in a sequential order as quickly and accurately as possible. In Part B, participants will be asked to complete a similar ordering task; however, this time alternating between numbered and lettered circles in ascending order (1–A–2–B, etc.). The time taken to complete each task will be recorded. In the Dimensional Change Card Sort Test, participants will be presented with stimuli (shape or colour), and cards. On each trial, participants are instructed to sort the cards according to the given stimuli (shape or colour). The sorting stimuli alternate, requiring the participant to change their response. The number of correct responses and response times will represent executive function’s performance. Verbal memory will be assessed with the Auditory Verbal Learning Test. Participants will be asked to recall as many words as possible after listening to a list of words (15 words) presented over three trials. The total number of words recalled across trials will be used as indices of verbal learning and memory. Attention will be assessed with the Flanker Inhibitory Control and Attention Test. Participants are shown a series of central target arrows flanked by distractor arrows pointing either in the same or opposite direction. Participants must indicate the direction of the central arrow whilst inhibiting the influence of flanking distractors. Accuracy and reaction time will be the primary measures of attention. Driving skills Driving skills assessment will be conducted using the Hyperdrive (Hyperdrive Australia Pty Ltd., Glynde, SA, Australia) driving simulator (C-DS model), which resembles the interior of a regular car and will follow the 4-part protocol set out by van Dijken [35]. The simulator software is running on SCANeRTM Studio v1.9 (AVSimulation, Boulogne-Billancourt, France). The visual simulation is provided by three 32-inch monitors. Introduction (10 min): Participants will drive on a winding road without traffic signs or other traffic to familiarise themselves with the driving simulator. Task 1 (15 min): Participants will drive along a rural road with traffic signs and other traffic. Participants will encounter six intersections with different traffic regulations and will be instructed to drive straight on each intersection and to comply with the traffic regulations. Additionally, at a certain point between two intersections a parked car will suddenly drive onto the road, close in front of the participant (with a time headway of 3 s). During the ride reaction time will be assessed by the following measures: the reaction time to an upcoming traffic light (turning amber at 111 m from the participant), the reaction time in response to the suddenly merging car, and the minimum time to collision (TTC) to the suddenly merging car. Furthermore, the average speed on road sections with different speed limits will be measured. There will be four road sections with a length of approximately 700 m each, two with a speed limit of 60 km/h and two with a speed limit of 80 km/h. Task 2 (5 min): Participants begin in an acceleration lane and will be instructed to merge into the traffic on the motorway, overtake a car and return to the left-hand lane. Traffic in the right-hand lane adopted a preferred distance to the car in front of them. This distance will increase for each consecutive car, making overtaking easier over time. Finally, participants will be instructed to leave the motorway and stop the car. Distance to other road users will be assessed using the following measures during the overtaking manoeuver: the time headway between the participant and the car in front of them, the time headway adopted by the car behind the participant, and the degree of deceleration of the car behind the participant. Task 3 (10 min): Participants perform a simulated version of the Road tracking test, which detects impairments in automatic driving behaviours. They will drive on a single lane for 10 min, without need for overtaking (as there will be no other cars). They are instructed to keep a constant speed of 100km/h. Outcome measures for this task include: the standard deviation of lateral position (SDLP; or ‘swerve’), the standard deviation of speed, and the average speed. SDLP has been shown to have good test-retest reliability, and within-participant changes due to external influences (i.e. training, alcohol) are independent of the driver’s baseline. Physical and cardiovascular health Measures of blood pressure, pulse, weight, height, waist circumference, grip strength and dexterity, pulse wave analysis and velocity, cardiorespiratory fitness, objective and self-reported physical activity, and sleep quality will be collected as follows: Physical activity: Physical activity will be assessed by self-report using the International Physical Activity Questionnaire (IPAQ-SF). The IPAQ-SF is a 9-item short-form questionnaire designed to assess a 7-day recall of physical activity behaviours separated into vigorous intensity (e.g. weight training), moderate intensity (e.g. leisure cycling), walking, and sitting [36]. An Actigraph wGT3X-BT device will be used to objectively measure physical activity engagement. Participants will be instructed to wear the wrist device on the wrist of the non-dominant hand at all times for 24 h/day for seven consecutive days. Valid day readings will be assessed as valid data collection of sleep measurements for 22–24h/day. A valid week reading will consist of a minimum of 4 days of valid day readings. Non-wear time will be defined as 0 counts per minute (cpm) for 90 min with an allowance of 2 min of activity when placed between two 30 min windows of 0 cpm. Participants will be instructed to wear the Actigraph for week 0 (prior to the intervention) and week 1 (1st week of the intervention) to determine differences in physical activity behaviour outside and inside of the intervention that may further influence adaptations. Dexterity and grip strength: The 9-hole pegboard test and grip strength assessments are standardised, quantitative assessments which will be used to assess finger dexterity and grip strength as both health measures and predictors of cardiovascular disease risk. The 9-hole pegboard test has been identified as a reliable measure of hand function with normative data available for healthy adults [37]. Participants are required to pick up metal pins in the holes in the board as quickly as possible, completing the same task in turn with the dominant hand, the non-dominant hand, and both hands. The grip strength assessment will be conducted using a dynamometer and is identified as a reliable measure of upper-body strength and a predictor of cardiovascular disease. Blood pressure and vascular stiffness: Pulse wave analysis (PWA) and pulse wave velocity (PWV) will be measured with the SphygmoCor® XCEL device (SphygmoCor® Technology, ATCOR CardieX Ltd) and XCEL version 1.3 software (SphygmoCor® Technology, ATCOR CardieX Ltd) using methods previously described [38]. Participants will be instructed to lay in a supine position, resting for a minimum of 10 min before fitting a standard adult brachial pneumatic cuff (23–33 cm) to measure systolic and diastolic pressures and capture a brachial waveform. Waveform analyses (PWA) will provide a central aortic waveform and non-invasive central blood pressure measurements. To assess PWV, participants will have a pneumatic thigh cuff fitted, and a tonometer placed on the carotid artery to simultaneously capture blood pressure waveforms at the carotid and femoral sites. The non-invasive pressures, along with the physical distance between the carotid and femoral sites, are then used to calculate PWV to provide an estimation of vascular stiffness, stratified for age and sex. Cardiorespiratory fitness: Cardiorespiratory fitness will be assessed through a submaximal volume of oxygen test. The validated Astrand-Rhyming protocol will be used to assess the physical capacity of participants, estimate participants’ maximal oxygen consumption (VO2 max) [39], and determine the intensity for the intervention sessions. Heart rate: Heart rate will be assessed using Polar H10 heart rate monitors (Polar Electro, Oy, Finland). These monitors will be used to assist participants in maintaining the correct exertion throughout the intervention. Other measures Dietary intake: The Cancer Council Victoria diet questionnaire (DQES version 3.2) will be completed and scored online. The DQES is a food frequency questionnaire that covers 80 items in 5 types of dietary intakes. It provides estimates of intake of major dietary categories. It has been validated in Australian adult individuals [40, 41]. Alcohol intake: The Alcohol Use Disorders Identification Test (AUDIT) questionnaire will be completed by participants and scored online. The AUDIT is a valid measure to assess drinking behaviours that are potentially harmful to participants [42]. Ten questions assessing the type, size, and number of alcoholic drinks consumed, as well as the frequency of intake, are scored from 0 to 4. A total score with a range 0–40 is computed, with a score of 1–7 suggesting low-risk, 8–14 suggesting hazardous intake, and 15 or more suggesting the likelihood of alcohol dependence. Mental health: Depression and anxiety symptomatology as well as wellbeing will be assessed on widely used validated scales. Symptoms of depression and anxiety were assessed by the Patient Health Questionnaire-9 (PHQ-9) [43] and Generalised Anxiety Disorder-7 (GAD-7) [44], respectively. These measures align closely with diagnostic criteria for major depressive disorder and generalised anxiety disorder respectively [45]. General psychological wellbeing over the last 2 weeks was measured using the World Health Organization Wellbeing Index (WHO-5) [46]. Sleep quality: Sleep quality and disorders will be assessed by self-report with the Pittsburgh Sleep Quality Index (PSQI) and the Mini Sleep Questionnaire (MSQ), and objectively with an Actigraph monitor. The PSQI is a short comprehensive self-reported tool (5–10 min) to assess sleep quality. PSQI obtains multiple aspects of sleep including bedtime, time to fall asleep, getting up time, sleep duration per night, frequency of trouble falling asleep, trouble sleeping, self-rating of sleep quality, sleep medicine usage, trouble staying awake during the day, daytime activity enthusiasm, bed partner/roommate, secondary evaluation of snoring, sleep apnoea, twitching or jerking, episodes of disorientation or confusion during sleep, restlessness. The MSQ [47] will be used to screen for possible sleep disorders. It is a short self-administered questionnaire that assesses daytime and night-time sleep disorders. It collects measures of difficulty falling asleep, waking up too early, hypnotic medication use, falling asleep, snoring, feeling tired upon waking up, mid-sleep awakenings, headaches on awakening, excessive daytime sleepiness, excessive movement during sleep. An Actigraph wGT3X-BT device will be used to objectively measure sleep duration, sleep efficiency, wake after sleep onset, and sleep fragmentation (see above for details). Acceptability Questionnaire: Developing an understanding of participants’ acceptance of physical activity interventions can benefit the development of future studies and interventions. Although some validated acceptability questionnaires are available in the literature, significant modifications are required to match the specific circumstances of the proposed study. An approach guided by a hybrid of the parsimony of the Single-Item Narcissism Scale [48] and the social psychology approach to ask about ‘someone like you’ rather than the individual themselves was applied to mitigate confounders associated with individual’s characteristics. A pre- and post-intervention quantitative questionnaire will require participants to answer four questions (e.g. ‘Would you recommend a simultaneous exercise and cognitive intervention to friends your age?’) using a 5-point Likert scale. Blood sample collection and analysis: Venous blood samples will be collected at the baseline and post-intervention assessments by a member of the research team trained in venipuncture. Three vacuettes, totaling 11mL of blood, will be collected. Two 3.5mL 3.2% sodium citrate vacuettes will be spun in a centrifuge (SIGMA 3-18KHS, Sigma, Germany) for 10 min at room temperature and 1000 G. The samples will then be aliquoted into 5 × 500 μL of plasma and stored in a laboratory freezer at −80 °C degrees. One sample collected in a 4mL K2EDTA vacuette will be run on Cell-DVN-Emerald Hematology Analyzer (Abbott) to retrieve full blood cell counts within 24 h. The remaining blood sample will be lysed with Pharmlyse (BD), aliquoted and stored at −80C at ANU. At the end of data collection, neurodegeneration (Neurofilament Light Chain, NFLs) and pro-inflammatory assays (TNF-α, interleukins) will be conducted in duplicate on all samples concurrently. Plans to promote participant retention and complete follow-up {18b} An active communication and monitoring strategy will be implemented to ensure retention and study completion. During data collection, we anticipate the majority of communication with our sample will take place face-to-face or by phone rather than through texts, emails, or other messaging platforms, given the communication habits of our target population. However, this approach may be modified as we will need to be agile to reflect recent changes in older adults’ communication preferences, which are rapidly evolving, and to ensure retention. If we note participants have recurring questions during recruitment and participation, we will collate these queries and design a simple frequently asked questions and answers list to be given to participants as needed. In addition, participants will be provided with some performance metrics (e.g. pulse, blood pressure, VO2max) after assessments or training sessions, and a summary physical activity report based on their objective assessment, to maintain their interest and support strong involvement. Participants who discontinue the intervention will be asked to fill in a brief exit questionnaire documenting the reasons for leaving the study. The research team will also record the reasons provided by discontinuing participants as well as the date of study exit. Moreover, the time of all training sessions undertaken and missed, and deviations from the intervention protocol will be recorded in a dedicated ledger. Data management {9} The majority of data will be collected in digital form through surveys or dedicated digital tools which will include a single ID code as an identifier. Consequently, the data will not need to be manually entered and the various data types will be linked by merging them into a single dataset. The validity of survey responses will be ensured through the implementation of on-the-fly automated checks of valid value ranges. The PhABHeaD Participants database will be stored on a secure ANU server. To ensure participant confidentiality, the Participant database will be stored securely in folders with user-level access permissions. Only named team members will have access. The PhABHeaD Research database, which will only contain participant IDs, will be stored on secure ANU and UC servers. All data will be stored for a minimum of 5 years. The use of the PhABHeaD research data will be guided by clear and fair governance principles developed by the research team and managed by the PhABHeaD steering committee. Any sensitive personal data recorded on physical media will be stored in locked filing cabinets only accessible by authorised personnel. Details of data management arrangements are documented in the study data management plan (available on request). Confidentiality {27} Privacy and Sensitive Personal Data: Sensitive personally identifiable data (name, DOB, addresses, contacts, etc.) of participants enrolled in the PhABHeaD study will be kept and stored in the study ‘Participants database’ separately from the de-identified research data stored in the ‘Research database’, such that all data within the PhABHeaD Research database is de-identified, but re-identifiable only by the study lead investigators (Rattray and Cherbuin) and data custodians. Each participant will be assigned a computer-generated unique ID code (from a register or random generator). This ID code will be stored both in the Participants database and in the Research database to ensure the research data is not stored with any sensitive, identifiable personal data, whilst still allowing the linking of newly collected data to existing participants’ research data. A separate ID will be generated for use in the field during data collection. All team members will be asked to acknowledge in writing before accessing any participant data that they will comply with the NHMRC guidelines in Human Research. Plans for collection, laboratory evaluation, and storage of biological specimens for genetic or molecular analysis in this trial/future use {33} Biological specimen (blood samples) will be collected in accordance with the present protocol. Samples collected in 2 × 3.5 mL 3.2% sodium citrate vacuettes will be spun and aliquoted into microcentrifuge tubes corresponding to the de-identified participant ID and stored in a secured laboratory fridge at −80 °C. The single 4 mL K2EDTA vacuette will be transferred to our Australian National University laboratory on the same day of sample collection for next-day analysis, and the remainder stored in −80 °C freezers for future concurrent analysis at the completion of the trial. For those participants who have formally consented for their samples to be made available for research beyond the aims of the current trial, biospecimens will be kept in storage indefinitely and their use will be subject to new ethics approvals being granted, otherwise they will be destroyed after 5 years post-trial end. Statistical methods Statistical methods for primary and secondary outcomes {20a} The efficacy of the intervention (primary aim) will be analysed within a multi-level modelling (MLM) framework. MLM reports maximum likelihood estimates and standard errors which are adjusted for potential intra-class clustering where repeated observations within the same individuals are likely correlated over time. As primary and secondary outcomes reflect variables with a combination of different distributions (e.g. Gaussian (normal), Binomial, Poisson), linear, logistic, and Poisson regressions can be easily implemented within a generalised MLM framework. As the intervention is a level-2 factor (between-person effect) the power of the analyses is drawn from the level 2 N, the number of individuals recruited into the study (see Power Analysis section for information on planned sample size estimate). Other analyses are proposed to answer secondary research questions. Appropriate analyses will be implemented to address each question. For example, cross-sectional analyses (e.g. baseline analyses of the sample on secondary outcomes) will be analysed within a generalised linear modelling (GLM) framework. Interim analyses {21b} Since this is not a clinical trial, there is no need for interim analyses to support monitoring. Analyses of baseline data may be conducted once the recruitment target has been achieved and all participants have completed the baseline assessment. All analyses investigating outcome measures will be conducted after the completion of the trial. Methods for additional analyses (e.g. subgroup analyses) {20b} Further exploratory analyses may be considered. Latent Class Analyses may examine combinations of risk factors which may moderate intervention efficacy. Mixture Growth analyses may examine whether particular risk/protective factors drive different trajectories in outcomes over time. For all analyses, results will balance the probability P of effects reported with the substantive size of effect. Owing to the interventional nature of the study, even small effects will be considered for their potential utility in a population health context (e.g. small effects may produce substantive meaningful population changes). We will also investigate the possible mediating effects of the intervention on outcome measures through mechanisms or other known mediating factors such as sleep, mental health, and cardiovascular risks. Methods in analysis to handle protocol non-adherence and any statistical methods to handle missing data {20c} Non-adherence to study protocol will most likely occur with incomplete training sessions or where the timing of assessments is adapted due to public holidays or participants’ availability (e.g. being away or unavailable and illness). Outcome data from all participants will be included in the data analysis following an ‘intention to treat’ analysis. Where participant data for particular assessment points are missing, the participant will still be retained in primary analysis as a benefit of the MLM approach is that missing data (either from missing an assessment or non-response on a single item at that assessment point) can be implemented with the Full information Maximum Likelihood (FIML) estimation method. Sensitivity analyses will consider the potential impact of missing data by comparing results from FIML models with results from imputation methods (i.e. multiple imputation using chained equations will derive and analyse at least 10 imputed datasets). Plans to give access to the full protocol, participant-level data, and statistical code {31c} Public access will be granted to the full protocol via publications, the study website, and on request. Access to participant-level data will be facilitated as part of collaborations and research consortia provided they meet ethical requirements, and on request to support the peer-review process. The research team will also endeavour to share statistical code through publications’ supplementary materials and research repositories. Oversight and monitoring Composition of the coordinating centre and trial steering committee {5d} The Trial Steering Committee is composed of the Chief Investigators, the trial manager, the trial administrator, and two members of the team responsible for the day-to-day administration of the intervention. It meets fortnightly to monitor possible adverse events, adequate recruitment strategies, staffing, and overall processes and strategies to ensure the safe, accurate, and timely delivery of the trial. In addition, the committee will consider any individual participant issues that may arise and require closer monitoring, remediation, or reporting to the approving ethics committees. Composition of the data monitoring committee, its role, and reporting structure {21a} A Data Monitoring Committee (DMC) is not needed because the treatments consist of activities that healthy individuals living in the community may undertake as part of a healthy lifestyle. Possible unintended outcomes are related to adverse events that will be monitored as part of normal trial delivery and, should they occur, will be immediately reported to the HREC. There is no data or biomarker collected that would warrant scrutiny before the end of the trial, and consequently, a DMC is not required. Adverse event reporting and harms {22} All adverse events will be systematically documented, reported to the approving HREC, and described in scientific publications. Frequency and plans for auditing trial conduct {23} Trials of this nature do not warrant external audits. However, any adverse events or complaints will be communicated to the HREC, discussed in detail by the Trial Steering Committee, and remedial or preventative actions will be developed and approved by the HREC, which is completely independent from the investigators and the sponsor. Monthly Trial Steering Committee meetings will also oversee and discuss the safe and consistent delivery of the trial. Plans for communicating important protocol amendments to relevant parties (e.g. trial participants, ethical committees) {25} Important protocol modifications require HREC approval and therefore will first be communicated and justified to the HREC and only implemented if approved. Any approved modification will be communicated to the ANZCTR, and the registered protocol details will be updated accordingly. Any such modifications will be communicated to participants through an updated participant information sheet and acknowledged in publications. Dissemination plans {31a} The primary means of trial results dissemination is through publication in peer-reviewed scientific journals and academic conference presentations. In addition, summary results will be communicated through press releases, public talks, stakeholder organisations’ newsletters, and on the study web site with an audience-appropriate overview of the results. There will be no publication restrictions except to meet journals’ copyright requirements. Discussion A major focus and concern of this study is not only to rigorously address the research questions but also to provide an enjoyable and uncomplicated experience to participants. This is to ensure that the methods implemented in the research can relatively seamlessly be transferred to preventive health interventions in the community and/or concrete and precise advice that can be provided to individuals who wish to integrate it in their daily routine. Given the active components selected, this should be highly feasible and relatively inexpensive since stationary bikes and subscription to the cognitive training application similar to those used in this trial are easily accessible and affordable. Nonetheless, once the trial is completed and the main results are reviewed and published, it will be particularly important to scrutinise participants’ feedback and the overall acceptability of the intervention to ensure that this methodology is not only efficacious but also perceived as sustainable and enjoyable, given one of the greatest challenges of population health interventions and particularly lifestyle interventions is to maintain long-term adherence. Another important outstanding question is the relative cost-effectiveness of the different conditions as significant but small differences in effect size between intervention arms may not justify possible additional costs. For this reason, detailed records of costs and resources used will be kept to enable future cost-effectiveness analyses. Finally, ensuring that equipment is available for participants at each training/assessment session is also an important consideration. Therefore, careful attention will be given to not over-book session times and maintaining access to spare cycle ergometers and assessment equipment to avoid faults interfering with the delivery of the intervention. Trial status Protocol version number: 1.0. Recruitment start date: May 2023. Expected recruitment completion: end 2025. Supplementary Information Supplementary Material 1. Acknowledgements Not applicable. Abbreviations Australian National University Australia and New Zealand Clinical Trial Registry Age predicted heart rate maximum Alcohol Use Disorders Identification Test Cognitive only training Data monitoring committee Full maximum information likelihood General Anxiety Disorder scale Generalised linear model Human research ethics committee iPhone Operating System Multi-level model Multiple sclerosis Mini Sleep Questionnaire Physical only training Patient Health Questionnaire Post-traumatic stress disorder Pittsburgh sleep quality index Pulse wave analysis Pulse wave velocity Randomised controlled trial Standard deviation of lateral position University of Canberra Maximal oxygen consumption World Health Organisation World Health Organization wellbeing index Biographies Nicolas Cherbuin is a Professor and Associate Director (research) in the National Centre for Epidemiology and Population Health, at the Australian National University, where he leads the Neuroimaging and Brain Lab (NIMBL). His background is in psychology, neuroscience, and epidemiology, and his research interests include the investigation of risk and protective factors for physical and cognitive ageing across the lifespan, and genetic-environmental interactions contributing to biological mechanisms implicated in ageing processes, mental health, and chronic disease. Joseph M. Northey is an Associate Professor in the School of Rehabilitation and Exercise Sciences at the University of Canberra. His research focuses on how physical activity affects brain health in children, adults, cancer survivors, and dementia. Erin I. Walsh is a senior research fellow in the National Center of Epidemiology and Population Health (NCEPH), at the Australian National University. She completed her PhD in self-report psychological research methods in 2015, and has subsequently published in the fields of brain ageing, morphometrics, science communication, education, and infectious disease. Her current focus is the use of visualisation as a tool for communicating population health information, with ongoing interests in cross-disciplinary methodological synthesis, and innovation in playful data collection. Richard A. Burns is an Associate Professor in the National Centre of Epidemiology and Population Health (NCEPH), at the Australian National University. Hollie Speer is a postdoctoral researcher in the Faculty of Health and Research Institute for Sport and Exercise, at the University of Canberra, and a member of the Active Brain Research Group. She has expertise in cardiovascular ageing and disease mechanisms within the vasculature. Her research interests include healthy ageing, women’s reproductive and cardiovascular health, and lifestyle (physical activity and nutrition) interventions to improve broad vascular health. Nicholas Lawlis is a PhD candidate in the Faculty of Health, Research Institute for Sport and Exercise, and Centre for Ageing Research and Translation at the University of Canberra. He is a member of the Active Brain Research group and an Accredited Exercise Physiologist. His research interests include investigating the role of physical activity for improving physical and cognitive health outcomes for people with young-onset dementia and healthy populations. Tergel Namsrai is a PhD candidate in the National Centre of Epidemiology and Population Health (NCEPH), at the Australian National University. She is a medical doctor with research interests in brain ageing, dementia, sleep, sociodemographic determinants of health, health service, and lived experience. Amanda Scott is a PhD candidate in the Faculty of Health and the Research Institute for Sport and Exercise at the University of Canberra. She is a member of the Active Brain Research Group and an Accredited Exercise Physiologist. Her research focuses on the effectiveness of combined cognitive and physical training in enhancing cognitive and physical performance in healthy populations. Vicki McCarthy is a PhD candidate in the Faculty of Health and the Research Institute for Sport and Exercise at the University of Canberra. She is a member of the Active Brain Research Group and an Accredited Exercise Physiologist with research interests in understanding how physical activity can influence brain ageing and cerebrovascular and cognitive function. Jo Lane is a clinical psychologist and Honorary Fellow at the National Centre of Epidemiology and Population Health (NCEPH), ANU. Her research interests include understanding the lived experience and improving quality of life for those living with chronic conditions including multiple sclerosis and age-related macular degeneration. Jeroen J. A. van Boxtel is an Associate Professor in the Discipline of Psychology, Faculty of Health, at the University of Canberra. He is a member of the Clinical Research Rehabilitation and Translation Area of Strength. He researches various aspects of attention, in relation to driving, and conscious awareness. He also studies social perception in relation to autism, and brain variability. He employs psychophysical experimentation, driving simulation, neuroimaging, and computational modelling to investigate these topics. Amit Lampit is an Associate Professor in the Department of Psychiatry, University of Melbourne. His research interests include biomarker-guided cognitive and behavioural interventions across the lifespan and brain disorders, computerised cognitive training, and evidence synthesis. Anne Brüstle is an Associate Professor in the John Curtin School of Medical Research, at the Australian National University. As an immunologist, her interest lies in the immune component of neurological conditions. She leads the Neuroimmunology and Multiple Sclerosis group at JCSMR and holds a senior fellowship from Multiple Sclerosis Australia. Ben Rattray is a Professor in the Faculty of Health and Research Institute for Sport and Exercise, at the University of Canberra, where he leads the Active Brain Research group. His background is in exercise physiology, and his research interests include investigating relationships between physical exercise and brain function, including healthy brain ageing. Authors’ contributions {31b} NC and BR are the Chief Investigators; they conceived the study, led the proposal and protocol development, sourced the funding, and oversaw the accurate delivery of the trial. JN contributed to the proposal and protocol development, led the delivery of the intervention and its monitoring, supervised the team delivering the intervention, and oversaw the participants’ recruitment and data collection. RB advised on the statistical methods. EW contributed to the proposal and protocol development, advised on communication and recruitment strategies, and assisted with the design of the advertising material. AB advised on the collection and processing of blood assays and oversaw their long-term storage as well as the Emerald processing. NL had primary responsibility for the day-to-day recruitment of participants, documentation of the trial, blood collection and pre-processing, and managed and contributed to the fitness assessment and the delivery of the physical training intervention. NL also programmed the driving scenarios, which were designed in collaboration with JJAVB. TN conducted the cognitive assessments, pulse wave velocity measurements, as well as overseeing the distribution and collection of the Actigraph physical activity monitors. VM contributed to the protocol development, pre-processing of blood products, and conduction of pre- and post-intervention physical and cognitive assessments. All authors read and approved the final manuscript. Funding {4} The study is in part funded by the ANU NRMA Driving Research Fund and the ANU Dementia Research and Prevention Fund. The Australian National University and the University of Canberra provide in-kind support through part of the investigators’ salary, infrastructure access, and equipment. Data availability {29} The Chief Investigators and other researchers contributing to collaborative projects approved by the study steering committee will have access to the data. Third parties involved in the publications’ review process will be provided access for this purpose. Declarations Ethics approval and consent to participate {24} The ethical aspects of this study were approved by the Australian National University (#2023/470) and the University of Canberra (#11846) Human Research Committees. Written, informed consent to participate will be obtained from all participants. Consent for publication {32} Model consent form and other related documentation given to participants will be provided on request. Competing interests {28} The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The Chief Investigators and other researchers contributing to collaborative projects approved by the study steering committee will have access to the data. Third parties involved in the publications’ review process will be provided access for this purpose.